| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| BRCA1 Protein | 24 | 2025 | 58 | 8.740 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 28 | 2024 | 34 | 7.160 |
Why?
|
| DNA Replication | 15 | 2024 | 236 | 4.330 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 20 | 2016 | 39 | 4.320 |
Why?
|
| DNA Repair | 25 | 2024 | 248 | 4.240 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 7 | 2025 | 22 | 3.150 |
Why?
|
| DNA Damage | 21 | 2024 | 287 | 2.810 |
Why?
|
| BRCA2 Protein | 6 | 2024 | 14 | 2.400 |
Why?
|
| DNA Breaks, Double-Stranded | 9 | 2022 | 88 | 2.320 |
Why?
|
| DNA Helicases | 11 | 2024 | 190 | 2.030 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 4 | 2025 | 19 | 2.020 |
Why?
|
| Drug Resistance, Neoplasm | 7 | 2025 | 198 | 1.880 |
Why?
|
| RNA Helicases | 5 | 2021 | 94 | 1.720 |
Why?
|
| DNA, Single-Stranded | 8 | 2025 | 107 | 1.710 |
Why?
|
| Neoplasms | 7 | 2024 | 1364 | 1.410 |
Why?
|
| Rad51 Recombinase | 6 | 2025 | 29 | 1.380 |
Why?
|
| Fanconi Anemia | 7 | 2014 | 15 | 1.370 |
Why?
|
| Breast Neoplasms | 12 | 2025 | 1198 | 1.360 |
Why?
|
| DNA | 12 | 2022 | 837 | 1.280 |
Why?
|
| Nuclear Proteins | 12 | 2025 | 778 | 1.240 |
Why?
|
| DNA-Binding Proteins | 15 | 2025 | 1186 | 1.160 |
Why?
|
| Homologous Recombination | 7 | 2025 | 28 | 1.130 |
Why?
|
| Mutation | 11 | 2021 | 2612 | 1.120 |
Why?
|
| Cell Line, Tumor | 13 | 2025 | 1469 | 1.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2025 | 429 | 1.020 |
Why?
|
| DNA Mismatch Repair | 4 | 2014 | 35 | 1.000 |
Why?
|
| MutS Homolog 2 Protein | 5 | 2024 | 28 | 0.910 |
Why?
|
| Ovarian Neoplasms | 6 | 2024 | 150 | 0.880 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 5 | 2025 | 14 | 0.850 |
Why?
|
| Genomic Instability | 6 | 2021 | 55 | 0.790 |
Why?
|
| Genes, BRCA2 | 3 | 2020 | 11 | 0.760 |
Why?
|
| Recombination, Genetic | 6 | 2010 | 246 | 0.720 |
Why?
|
| Chromatin | 1 | 2025 | 608 | 0.680 |
Why?
|
| DNA Mutational Analysis | 1 | 2021 | 197 | 0.670 |
Why?
|
| Transcription Factors | 6 | 2018 | 1513 | 0.670 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 130 | 0.660 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2023 | 564 | 0.610 |
Why?
|
| Humans | 46 | 2025 | 63443 | 0.610 |
Why?
|
| Animals | 19 | 2025 | 20663 | 0.490 |
Why?
|
| Cisplatin | 4 | 2021 | 139 | 0.480 |
Why?
|
| Ploidies | 1 | 2015 | 3 | 0.470 |
Why?
|
| DNA Repair Enzymes | 6 | 2016 | 37 | 0.460 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2015 | 17 | 0.460 |
Why?
|
| Cytological Techniques | 1 | 2015 | 26 | 0.460 |
Why?
|
| Vaginal Smears | 1 | 2015 | 56 | 0.460 |
Why?
|
| MutL Protein Homolog 1 | 6 | 2014 | 27 | 0.450 |
Why?
|
| Mitomycin | 5 | 2021 | 26 | 0.440 |
Why?
|
| Lysine | 2 | 2012 | 83 | 0.440 |
Why?
|
| Autoantigens | 1 | 2015 | 137 | 0.430 |
Why?
|
| Ultraviolet Rays | 1 | 2013 | 137 | 0.400 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2011 | 198 | 0.390 |
Why?
|
| DNA-Directed DNA Polymerase | 2 | 2024 | 15 | 0.380 |
Why?
|
| Acetylation | 1 | 2012 | 120 | 0.380 |
Why?
|
| Cell Line | 8 | 2021 | 2040 | 0.380 |
Why?
|
| Cell Cycle Proteins | 5 | 2025 | 396 | 0.360 |
Why?
|
| Replication Protein A | 3 | 2021 | 13 | 0.360 |
Why?
|
| Mice | 8 | 2025 | 10844 | 0.350 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2010 | 5 | 0.340 |
Why?
|
| Signal Transduction | 4 | 2010 | 3035 | 0.320 |
Why?
|
| HeLa Cells | 5 | 2021 | 536 | 0.320 |
Why?
|
| S Phase | 2 | 2024 | 78 | 0.310 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 3 | 2016 | 6 | 0.310 |
Why?
|
| Female | 15 | 2025 | 32878 | 0.290 |
Why?
|
| Protein Binding | 8 | 2024 | 1603 | 0.260 |
Why?
|
| MRE11 Homologue Protein | 4 | 2021 | 6 | 0.260 |
Why?
|
| GTP-Binding Proteins | 2 | 1996 | 84 | 0.240 |
Why?
|
| Histones | 2 | 2025 | 481 | 0.240 |
Why?
|
| Gene Knockout Techniques | 2 | 2021 | 95 | 0.210 |
Why?
|
| Small Molecule Libraries | 1 | 2024 | 58 | 0.210 |
Why?
|
| Nucleotidyltransferases | 1 | 2024 | 61 | 0.210 |
Why?
|
| CRISPR-Cas Systems | 2 | 2025 | 361 | 0.210 |
Why?
|
| HEK293 Cells | 2 | 2018 | 622 | 0.210 |
Why?
|
| Recombinational DNA Repair | 3 | 2020 | 25 | 0.210 |
Why?
|
| Genes, BRCA1 | 3 | 2016 | 16 | 0.200 |
Why?
|
| Adenosine Triphosphatases | 5 | 2009 | 255 | 0.200 |
Why?
|
| DNA Ligase ATP | 1 | 2021 | 1 | 0.180 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2021 | 9 | 0.180 |
Why?
|
| G-Quadruplexes | 1 | 2021 | 6 | 0.180 |
Why?
|
| Single Molecule Imaging | 1 | 2021 | 22 | 0.170 |
Why?
|
| Loss of Function Mutation | 1 | 2021 | 23 | 0.170 |
Why?
|
| Histone Chaperones | 1 | 2020 | 7 | 0.170 |
Why?
|
| Carrier Proteins | 5 | 2016 | 707 | 0.170 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2021 | 67 | 0.170 |
Why?
|
| Codon, Nonsense | 1 | 2021 | 58 | 0.170 |
Why?
|
| Cross-Linking Reagents | 1 | 2021 | 117 | 0.170 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 525 | 0.160 |
Why?
|
| Mutation, Missense | 1 | 2021 | 186 | 0.160 |
Why?
|
| Chromosome Aberrations | 2 | 2021 | 67 | 0.150 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2014 | 219 | 0.150 |
Why?
|
| HCT116 Cells | 1 | 2018 | 51 | 0.150 |
Why?
|
| Immunoprecipitation | 2 | 2010 | 127 | 0.140 |
Why?
|
| Phosphorylation | 2 | 2013 | 936 | 0.140 |
Why?
|
| Phospholipase D | 1 | 1996 | 6 | 0.130 |
Why?
|
| Fetus | 1 | 2016 | 99 | 0.130 |
Why?
|
| ras Proteins | 1 | 1996 | 77 | 0.130 |
Why?
|
| Computational Biology | 1 | 2017 | 356 | 0.120 |
Why?
|
| Markov Chains | 1 | 2015 | 37 | 0.120 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2016 | 284 | 0.120 |
Why?
|
| Models, Biological | 2 | 2013 | 1180 | 0.120 |
Why?
|
| Gene Deletion | 1 | 2016 | 309 | 0.110 |
Why?
|
| Leucine Zippers | 2 | 2005 | 12 | 0.110 |
Why?
|
| GTPase-Activating Proteins | 1 | 1995 | 69 | 0.110 |
Why?
|
| GTP Phosphohydrolases | 1 | 1995 | 60 | 0.110 |
Why?
|
| Fungal Proteins | 1 | 1995 | 147 | 0.110 |
Why?
|
| Fanconi Anemia Complementation Group A Protein | 1 | 2014 | 5 | 0.110 |
Why?
|
| RecQ Helicases | 2 | 2011 | 9 | 0.110 |
Why?
|
| Mice, Mutant Strains | 1 | 2014 | 302 | 0.110 |
Why?
|
| Lentivirus | 2 | 2021 | 66 | 0.100 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 311 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2012 | 1617 | 0.100 |
Why?
|
| Transfection | 3 | 2005 | 694 | 0.100 |
Why?
|
| G2 Phase Cell Cycle Checkpoints | 1 | 2012 | 5 | 0.100 |
Why?
|
| Protein Transport | 1 | 2013 | 402 | 0.100 |
Why?
|
| Histone Acetyltransferases | 1 | 2012 | 59 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2004 | 248 | 0.090 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 322 | 0.090 |
Why?
|
| Bloom Syndrome | 1 | 2011 | 2 | 0.090 |
Why?
|
| MutL Proteins | 2 | 2008 | 10 | 0.090 |
Why?
|
| Mismatch Repair Endonuclease PMS2 | 2 | 2008 | 9 | 0.090 |
Why?
|
| Antineoplastic Agents | 2 | 2024 | 663 | 0.090 |
Why?
|
| Neoplasm Proteins | 3 | 2008 | 281 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2002 | 363 | 0.080 |
Why?
|
| Molecular Sequence Data | 4 | 2006 | 1991 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2010 | 612 | 0.080 |
Why?
|
| Cohort Studies | 1 | 2015 | 2570 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 525 | 0.070 |
Why?
|
| Multiprotein Complexes | 1 | 2008 | 154 | 0.070 |
Why?
|
| Chromosomal Instability | 2 | 2020 | 20 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 2 | 2006 | 456 | 0.070 |
Why?
|
| Ubiquitin | 1 | 2007 | 99 | 0.060 |
Why?
|
| Chromosome Mapping | 2 | 2005 | 289 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2021 | 702 | 0.060 |
Why?
|
| cdc42 GTP-Binding Protein, Saccharomyces cerevisiae | 2 | 1996 | 7 | 0.060 |
Why?
|
| Genes, Dominant | 1 | 2006 | 57 | 0.060 |
Why?
|
| Retroviridae | 1 | 2006 | 74 | 0.060 |
Why?
|
| G2 Phase | 1 | 2005 | 24 | 0.060 |
Why?
|
| Cell Nucleus | 3 | 2021 | 629 | 0.060 |
Why?
|
| DNA Primers | 1 | 2005 | 293 | 0.060 |
Why?
|
| Genes, Reporter | 1 | 2005 | 257 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 1147 | 0.050 |
Why?
|
| Cell Survival | 1 | 2006 | 575 | 0.050 |
Why?
|
| Cell Division | 1 | 2005 | 450 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2004 | 45 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 367 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2006 | 673 | 0.050 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2008 | 426 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 240 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2024 | 373 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2024 | 385 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2024 | 864 | 0.050 |
Why?
|
| Carcinoma, Papillary | 1 | 2001 | 36 | 0.050 |
Why?
|
| Thyroidectomy | 1 | 2001 | 31 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2008 | 678 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2006 | 1592 | 0.050 |
Why?
|
| Sf9 Cells | 1 | 2021 | 8 | 0.040 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2021 | 29 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2001 | 24 | 0.040 |
Why?
|
| Biophysics | 1 | 2021 | 42 | 0.040 |
Why?
|
| Thyroid Neoplasms | 1 | 2001 | 74 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2002 | 220 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2001 | 153 | 0.040 |
Why?
|
| Transgenes | 1 | 2021 | 187 | 0.040 |
Why?
|
| Boston | 1 | 2001 | 253 | 0.040 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2001 | 94 | 0.040 |
Why?
|
| Acid Anhydride Hydrolases | 2 | 2013 | 5 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2001 | 134 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2001 | 719 | 0.040 |
Why?
|
| Biopsy | 1 | 2021 | 443 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2021 | 921 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2002 | 337 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2002 | 309 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 489 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2011 | 2157 | 0.040 |
Why?
|
| Binding Sites | 1 | 2001 | 905 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1998 | 72 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2017 | 89 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2021 | 988 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2017 | 87 | 0.030 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2016 | 12 | 0.030 |
Why?
|
| rap GTP-Binding Proteins | 1 | 1996 | 2 | 0.030 |
Why?
|
| rac GTP-Binding Proteins | 1 | 1996 | 16 | 0.030 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2016 | 32 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2016 | 124 | 0.030 |
Why?
|
| Rats | 2 | 2002 | 1980 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2016 | 238 | 0.030 |
Why?
|
| ral GTP-Binding Proteins | 1 | 1995 | 4 | 0.030 |
Why?
|
| Genome, Human | 1 | 2017 | 237 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1995 | 150 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2016 | 157 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1995 | 165 | 0.030 |
Why?
|
| Immunoblotting | 1 | 1995 | 204 | 0.030 |
Why?
|
| Gene Library | 1 | 1995 | 102 | 0.030 |
Why?
|
| Stem Cells | 1 | 2016 | 259 | 0.030 |
Why?
|
| Genotype | 1 | 2016 | 663 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 1995 | 415 | 0.030 |
Why?
|
| Ficusin | 1 | 2013 | 4 | 0.030 |
Why?
|
| Radiation, Ionizing | 1 | 2013 | 15 | 0.030 |
Why?
|
| Prognosis | 1 | 2017 | 1748 | 0.020 |
Why?
|
| Endodeoxyribonucleases | 1 | 2013 | 44 | 0.020 |
Why?
|
| Base Sequence | 1 | 1995 | 1331 | 0.020 |
Why?
|
| Liver | 1 | 2016 | 855 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2016 | 2109 | 0.020 |
Why?
|
| Apoptosis | 1 | 2016 | 1079 | 0.020 |
Why?
|
| Insecta | 1 | 2011 | 37 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2011 | 68 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2011 | 292 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2008 | 43 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2009 | 144 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2008 | 52 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2009 | 293 | 0.020 |
Why?
|
| Catalysis | 1 | 2006 | 161 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 191 | 0.020 |
Why?
|
| Kinetics | 1 | 2007 | 763 | 0.010 |
Why?
|
| DNA, Cruciform | 1 | 2005 | 5 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2005 | 381 | 0.010 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2008 | 445 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2005 | 339 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 2005 | 239 | 0.010 |
Why?
|
| Adult | 1 | 2001 | 16823 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2006 | 392 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2001 | 196 | 0.010 |
Why?
|
| Zygote | 1 | 1998 | 45 | 0.010 |
Why?
|
| Meiosis | 1 | 1998 | 66 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2002 | 1149 | 0.010 |
Why?
|
| Mitosis | 1 | 1998 | 218 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1998 | 864 | 0.010 |
Why?
|